Joseph Jankovic, M.D. (US) received his M.D. degree at the University of Arizona, and completed his medicine internship at Baylor College of Medicine, Houston in 1974. He subsequently completed residency in Neurology at the Neurological Institute, Columbia University, New York City, where he was selected as the Chief Resident. While there he obtained additional training in movement disorders with Dr. Stanley Fahn. In 1977 he joined the faculty of Baylor College of Medicine and established the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC). The PDCMDC has been recognized as a "Center of Excellence” by the National Parkinson Foundation and the Huntington Disease Society of America. Promoted to a full professor of Neurology in 1988, Dr. Jankovic holds the endowed Baylor College of Medicine Distinguished Chair in Movement Disorders.
Dr. Jankovic has published over 700 original articles and chapters and has edited or co-edited 35 books and volumes, including several standard textbooks such as "Neurology in Clinical Practice” (NICP.com) and "Parkinson's Disease and Movement Disorders” (along with a video atlas), both currently in 5 th edition. Dr. Jankovic, along with Dr. Fahn, co-authored a comprehensive book (and DVD) entitled "Principles and Practice of Movement Disorders”, published in 2007.
Dr. Jankovic is past president of the international Movement Disorder Society. He is a recipient of the 2007 AAN Movement Disorders Research Award, sponsored by the Parkinson's Disease Foundation. Other honors include election as an Honorary Member of the American Neurological Association, Australian Association of Neurologists, Panamanian Neurosurgical and Neurological Society, and French Neurological Society. In 2004 Dr. Jankovic was selected by fellow scientists as Highly Cited Researcher (ISIHighlyCited.com). He has served on editorial boards of Neurology, Movement Disorders, Journal of Neurology Neurosurgery and Psychiatry, Acta Neurologica Scandinavica, Journal of Neurological Sciences, Neurology Medlink, Clinical Neuropharmacology, Expert Review of Neurotherapeutics, The Botulinum Journal, and other journals. (For further information log on to www.jankovic.org ).
Jim Allen, ACFRE, MBA is a senior fundraising executive with a wealth of experience in serving the not-for-profit sector in education, health care and social services. Some of Jim’s key accomplishments as a professional fundraiser and a fundraising consultant include revitalizing fundraising campaigns, developing corporate relationships, public relations and managing staff and volunteers. His expertise runs the gamut of fundraising initiatives from annual giving and major gifts programs to campaign management and planned giving. A pioneer in introducing innovative concepts and initiatives to traditional fundraising activities, Jim has built a demonstrated record of accomplishment in all aspects of the field.
During his career Jim has worked at major universities including the University of Massachusetts, The University of Maryland School of Medicine, The University of Toronto and York University. Jim has also worked for several other prestigious organizations including Cleveland Public Radio, Ohio Presbyterian Homes, The Hearing Foundation of Canada and the Ontario Sailing Association. Jim currently serves as Director, Resource Development for Parkinson Society Canada.
Jim has played a key role within the Association of Fundraising Professionals (AFP). He has served as AFP Cleveland Chapter President, AFP International Board Member and was elected to two terms on the AFP Greater Toronto Chapter Board of Directors. Jim is also a long time member of the Toronto Roundtable of the Canadian Association of Gift Planners (CAGP). Jim currently sits on the ACFRE Certification Board having been elected to a four year term from January 1, 2009-December 31, 2012. He is serving as ACFRE Certification Board Chair for 2011.
Jim was awarded the Advanced Certified Fundraising Executive (ACFRE) designation in 2004 from the Association of Fundraising Professionals, the largest community of professional fundraisers in the world. Available only to senior-level fundraisers who have worked in the profession for ten or more years, the ACFRE is a distinguished achievement earned by only 91 professionals since the inception of the program in 1993. Jim is one of only six Canadians to be awarded this designation.
Susan H Fox, MB ChB, MRCP (UK), PhD is Associate Professor Neurology, University of Toronto and Staff Neurologist Movement Disorders Clinic, Toronto Western Hospital, UHN, Canada. She performed her medical and neurological training in Manchester and Liverpool, UK. Appointed Consultant Neurologist, Walton Centre Liverpool 2001-2003. Moved to Canada in 2003 to take up current position. Research interests include preclinical studies of Parkinson’s disease investigating disease mechanisms, particularly neuropsychiatric problems as well as phase II and phase III clinical trials of new treatments for movement disorders. Currently also chair of the Movement Disorder society evidence based medicine update on treatment of motor symptoms for Parkinson’s disease.
Mark Guttman, MD (Canada) provides specialized neurological services to patients with movement disorders and is involved with clinical research at our Centre and at the University of Toronto.
Wolfgang Oertel, MD, PhD (Germany) is Director of the Department of Neurology at the Philipps University of Marburg.
Rajesh Pahwa, MD (US), is Professor in the Department of Neurology and Director of the Parkinson’s Disease and Movement Disorder Center at the University of Kansas School of Medicine in Kansas City.
Upon attainment of his MBBS (MD) degree at Seth G.S. Medical College, University of Bombay, India, Dr. Pahwa completed an internship in medicine at Baylor College of Medicine followed by a residency in Neurology at Baylor College of Medicine, Houston, Texas. He then completed a one-year fellowship in movement disorders at the University of Kansas Medical Center before joining the faculty of the Department of Neurology as an Instructor in 1992.
Dr. Pahwa is a Diplomat of the American Board of Psychiatry and Neurology. His research interests are centered around the various aspects of Parkinson’s disease and essential tremor. He is currently involved in various studies related to medical and surgical forms of therapies for Parkinson’s disease and essential tremor. Dr. Pahwa has published over 100 peer-reviewed articles. In addition he has published numerous chapters and abstracts in leading neurology and movement disorder journals. He has conducted over 50 clinical trials related to Parkinson’s disease and other movement disorders. He is the co-editor of "Handbook of Parkinson’s Disease,” 3rd and 4th editions, "Therapy of Parkinson's Disease," 3rd edition, "Handbook of Essential Tremor and other Tremor Disorders,” 1st edition, and co-author of the book "Parkinson’s Disease: Questions and Answers,” 4th edition. He is also the Co-Editor in Chief of the International Journal of Neuroscience. He is also an active member of American Academy of Neurology, American Neurological Association, Movement Disorder Society, Kansas City Neurology Neurosurgery Society, Parkinson Study Group, and Tremor Research Group.
Michel Panisset, MD (Canada) is currently Professor of Medicine at the Université de Montréal, associate member at the Montral Neurological Hospital and head of Neurology at CHUM. He is co-Director of the André-Barbeau Movement Disorders Clinic of CHUM and co-director of the McGill-University of Montréal Movement disorder functional surgery program. Dr Panisset and his team care for near 5000 patients with Parkinson disease and other movement disorders and the surgical program has allowed near 250 patients to receive deep brain stimulation.
He received his MD degree from the Université de Montréal and trained in neurology at the University of Pittsburgh, Pennsylvania. He further specialized in movement disorders and dementia at INSERM, Paris, France and then at McGill University, Montréal. He obtained a Diplôme d'Études Approfondies (DEA) in neuropsyhology at the Université Claude Bernard in Lyon, France.
Werner Poewe, M.D. (Austria) is a Professor of Neurology and the Director of the Department of Neurology at Innsbruck Medical University in Innsbruck, Austria. He held a Residency in Clinical Neurology and Psychiatry at the University of Innsbruck, Austria, from 1977 to 1984. Then, Professor Poewe was a British Council Research Fellow at University College and Middlesex Hospital Medical School, London. For three years (1986-1989), he was a Senior Lecturer in the Department of Neurology at the University of Innsbruck, Austria. From 1990 through 1994 he served as Professor of Neurology and Acting Director of the Department of Neurology at the Virchow Hospital of the Free University of Berlin. Professor Poewe’s main research interests are in the field of movement disorders with particular emphasis on the clinical pharmacology of Parkinson’s disease and dystonia. He has authored and co-authored more than 400 original articles and reviews in the field of movement disorders. He served as President of the International Movement Disorder Society from 2000 through 2002, as President of the Austrian Society of Neurology from 2002 to 2004 and is the current President of the Austrian Parkinson’s Disease Society.
Olivier RASCOL, MD, PhD is Professor of Clinical Pharmacology and Neuropharmacolgy in Toulouse University Hospital since 1993. He obtained his MD in Neurology (Toulouse, 1985) and his PhD in Neurosciences (Paris, 1992). Dr Rascol is running the Toulouse Clinical Research Centre since 1994 and the Toulouse European Space Clinic since 1998. He is running a Research Group on Motricity in the Research Unit INSERM U825 and is head of the French Reference Center for Multiple System Atrophy (Atypical Parkinsonism) since 2006.
As a neuropharmacologist, Dr Rascol’s main fields of interest are Parkinson’s disease and movement disorders, drug development for Parkinson’s disease and functional neuroimaging. Dr Rascol is currently running several research programs on neuroprotection, new dopaminergic and non-dopaminergic antiparkinsonian medications in collaboration with several research centres in the US and in Europe. He is acting in this field as an external advisor for French and European scientific organisations, patients’ associations, drug agencies and international pharmaceutical companies.
Dr. Rascol is member of several international neurological and pharmacological societies. He is a member of the MDS Educational Committee, of the WFN Research Committee on Parkinsonism and Related Disorders and of the MDS EBM and Rating Scales Taskforces. Dr. Rascol is working as associate-editor for the Journal of Neural Transmission and is a member of the editorial board of the Lancet Neurology, and the European Journal of Neurology.
Dr. Rascol has published 300 articles in International Scientific journals (New England Journal of Medicine, Lancet, Annals of neurology, Neurology, Archives of neurology, Brain, Movement Disorders…). He has also been invited to give more than 250 lectures in various European, North and South American and Asian universities or national and international meetings.
Kapil D. Sethi, MD, FRCP, Panelist (US) who is Board-certified in Neurology and Internal medicine, earned his medical degree at the Christian Medical College, Ludhiana, India. After completing a research fellowship in neurology at the Charing Cross Group of Hospitals and Medical School, London, UK, he was a Registrar in Neurology at the Welsh National School of Medicine at Morriston Hospital, and a Neurology resident at the Medical College of Georgia.
Dr. Sethi is a Fellow of the American Academy of Neurology (AAN) and the Royal College of Physicians (London); the Vice President of the Tremor Research Group, and a member of the American Neurological Association (ANA), the Movement Disorder Society (MDS), and the American Association of Physicians from India. Dr. Sethi’s research interests are in Parkinson’s disease, restless legs syndrome, and cervical dystonia, and he has participated as principal investigator in numerous clinical trial and research studies.
An author of numerous reviews, abstracts, book chapters, and journal articles, Dr. Sethi’s work has been published in peer-reviewed publications, including Neurology, Movement Disorders and Annals of Neurology. He serves as an editorial reviewer for the journals Movement Disorders, Neurology, Brain, Annals of Neurology and The New England Journal of Medicine, and is a section editor for Current Neurology and Neurosciences Reviews and Medscape Neurology. He has served on the editorial boards of Movement Disorders and AAN.com.
Debra Shaw (Canada) is Parkinson Society Canada’s Corporate and Foundation Officer.
Fabrizio Stocchi, MD, PhD (Italy) is Professor of Neurology, Consultant in Neurology and Director of the Parkinson’s disease and Movement disorders research centre at the Institute for Research and Medical Care IRCCS San Raffaele Rome and University "La Sapienza” Rome. He is also Scientific advisor of the Institute for Parkinson’s Disease Research in Vicenza. Professor Stocchi was awarded his MD from the University of L’Aquila and his PhD from the University of Catania.
Professor Stocchi’s research activities have centred on neuropharmacology in the field of movement disorders and neurodegenerative diseases. He has published many books and papers on the genetics, clinical diagnosis, xtrapyramidal n and treatment of Parkinson’s disease, as well as in preclinical research into the disease. He is an active member of 11 societies, including the Movement Disorders Society, the WFN society where is member of the xtrapyramidal committee, the European Clinical Neuropharmacology Society and the European Federation Neurological Society.
Oksana Suchowersky MD FRCPC FCCMG is currently Professor of Neurology and Medical Genetics at the Faculty of Medicine, University of Alberta
Dr. Suchowersky received her B.Sc. (Honors) from the University of Alberta, M.Sc from the University of British Columbia, and MD from University of Calgary. Following residency in Neurology at University of British Columbia, Dr. Suchowersky was recruited to the University of Calgary Faculty of Medicine to develop the Movement Disorders Program in 1984. She was the first Neurologist with specific training in Movement Disorders in the province, training with Dr. Donald Calne at University of British Columbia. Under her leadership the program grew to an internationally recognized center for care of patients with Parkinson’s disease, and related movement disorders. She was instrumental in developing the research program in Parkinson Disease. Her research interests include understanding the genetic factors related to the development of neurodegenerative disorders, and developing new treatments for these disorders. In collaboration with the University of Lethbridge, an active program studying physical therapy in Parkinson disease was also developed.
She has published almost 200 peer-reviewed publications, and edited 2 books. She is on the Editorial Board of Canadian Journal of Neurological Sciences, Nature Clinical Neurology, and International Neurological Journal. She is a member of the Parkinson Study Group, Huntington Study Group, and is currently on the Executive Committee of NET-PD. She was the President of Canadian Neurological Society, and Canadian Congress of Neurological Sciences. From 2005 – 2010, she served as a Department Head in Medical Genetics, Faculty of Medicine at the University of Calgary. She is now the Toupin Research Chair in Neurology at the University of Alberta.
Eduardo Tolosa, M.D. (Spain) received his degree from the University of Barcelona. He obtained his neurological training at the University of Minnesota Hospital in Minneapolis . He was Visiting Scientist at Brookhaven National Hospital where he worked with George Cotzias during 1974 and 1975, and subsequently he joined the faculty of the Department of Neurology at the University of Minnesota. He was later appointed Chief of Neurology at the University Hospital in Barcelona in 1982. He is Professor of Neurology at the University of Barcelona and the Director of the Parkinson Disease and Movement Disorder Centre at the University of Barcelona Hospital.
Prof. Tolosa was certified as a neurologist by the American Board of Neurology and Psychiatry in 1976. He became a Fellow of the in 1997. He is a Fellow of the American Academy of Neurology and the American Neurological Association and of the Royal College of Physicians and founding member of the Movement Disorder Society (MDS) . He has been President of this Society and President of the European Neurological Society. Prof. Tolosa is an honorary member of several neurological societies including the British Neurological Association and the French Neurological Society.
Prof. Tolosa's research and publication activities have brought him appointments to various peer-review journals. He is, for example, a member of the International Advisory Committee of the Archives of Neurology and has served as member of the editorial board of the European Journal of Neurology, Movement Disorders, Practical Neurology, the Journal of Neurology Neurosurgery and Psychiatry and the Journal of Neurology.
Prof. Tolosa's research interest have centered on movement disorders and particularly in issues related to experimental therapeutics, etiology and pathophysiology of various Parkinson syndromes. His team has investigated on the clinical and molecular genetics of Parkinson disease and progressive supranuclear palsy. They demonstrated that an extended tau gene haplotype (H1E) in its homozygous state is overrepresented in PSP and described the only homozygous tau mutation so far in patients with PSP syndrome. He has also investigated in collaboration with neurophysiologist in his department brainstem mechanisms underlying several movement disorders such as dystonia and the various Parkinson syndromes defining the presence of brainstem abnormalities in various focal dystonias and atypical parkinsonisms.
In the areas of experimental therapeutics Professor Tolosa was involved in pioneer studies defining mechanisms underlying levodopa related motor fluctuations, both, in patients and in animal models of parkinsonism and his team has been among the first in Europe to evaluate efficacy of novel surgical strategies for Parkinson disease such as subthalamic nucleus stimulation and its impact upon patients cognition and quality of life.